Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT06949267
What this trial is testing

IMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-Host Disease
Ruijin Hospital 56
Not applicableLooking for participantsNCT06041893
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Samsung Medical Center 20
Not applicableStudy completedNCT04760184
What this trial is testing

Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden

Who this might be right for
Covid19Myeloma MultipleMalignant Lymphoma+2 more
Uppsala University 20
Not applicableEnded earlyNCT02338232
What this trial is testing

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD
Hackensack Meridian Health 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT05907499
What this trial is testing

Decitabine for Poor Graft Function Post Allo-HSCT

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 76
Testing effectiveness (Phase 2)Ended earlyNCT00034528
What this trial is testing

Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

Who this might be right for
HemoglobinopathiesAnemia, Sickle CellHemoglobin SC Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT04282421
What this trial is testing

Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France

Who this might be right for
Myelofibrosis
Central Hospital, Nancy, France 58
Large-scale testing (Phase 3)Ended earlyNCT00241345
What this trial is testing

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

Who this might be right for
Cytomegalovirus Infections
Washington University School of Medicine 39
Not applicableUnknownNCT05667428
What this trial is testing

Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT

Who this might be right for
Hematopoietic Stem Cell TransplantationPremature Ovarian Failure
First Affiliated Hospital Xi'an Jiaotong University 200
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Not applicableStudy completedNCT02300961
What this trial is testing

Feasibility Neurocognitive Outcome After Transplant

Who this might be right for
Stem Cell TransplantationPediatric CancerAcute Lymphoblastic Leukemia
Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT05987124
What this trial is testing

Defibrotide Dose-escalation for SOS Post-HSCT

Who this might be right for
Sinusoidal Obstruction SyndromeVeno-occlusive Disease
New York Medical College 20
Not applicableUnknownNCT02320942
What this trial is testing

Exercise Post Bone Marrow Transplant

Who this might be right for
Leukemia
University of British Columbia 20
Not applicableEnded earlyNCT05224661
What this trial is testing

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Who this might be right for
Acute Myeloid Leukemia in Remission
Center for International Blood and Marrow Transplant Research 303
Early research (Phase 1)Looking for participantsNCT07280494
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Who this might be right for
CD7+ T-ALL/LBL
Peking University People's Hospital 18
Early research (Phase 1)WithdrawnNCT02526329
What this trial is testing

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
Everett Meyer
Testing effectiveness (Phase 2)Study completedNCT00058305
What this trial is testing

Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more
National Cancer Institute (NCI) 28
Not applicableStudy completedNCT03509051
What this trial is testing

Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantMeningococcal Vaccine
Assistance Publique - Hôpitaux de Paris 40
Large-scale testing (Phase 3)Study completedNCT00784537
What this trial is testing

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 520
Next Page